Adagio Medical Holdings, Inc. Cash Flow Statement
ADGM|2 years of annual SEC 10-K data (FY2024-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 2 fiscal years. All figures from audited SEC 10-K filings.
Adagio Medical Holdings, Inc. used $19M in operating cash flow and negative free cash flow of $19M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 |
|---|---|---|
| Net Income | -$25.1M | -$21.3M |
| Depreciation & Amortization | $970.0K | $646.0K |
| Operating Cash Flow | -$19.0M | -$16.0M |
| Capital Expenditures | $374.0K | $368.0K |
| Free Cash Flow | -$19.4M | -$16.4M |
| FCF Margin | - | -4912.3% |